
Aveed’s Impact on Aging: A Longitudinal Study in American Men with Hypogonadism
Reading Time: 2 minutes Introduction Aging is an inevitable process that brings about numerous physiological changes in men, particularly related to testosterone levels. Aveed, a long-acting testosterone injection developed by Endo Pharmaceuticals, has been a subject of interest in managing these changes. This article delves into a longitudinal study examining Aveed's impact on aging in American men, offering valuable insights into its efficacy and safety. The Study Design The longitudinal study involved a cohort of 500 American men aged between 40 and 75 years, all diagnosed with hypogonadism, a condition characterized by low testosterone levels. Participants were administered Aveed injections every 10 weeks for...